CRVS
Corvus Pharmaceuticals, Inc. · Healthcare
Orbimed Advisors LLC bought $648K of Corvus Pharmaceuticals, Inc.
Director and 10% owner
Bought$648,100
$12.96Price
50,000Shares
+1%Stake
What CRVS did for a copier
Prices for CRVS after this filing aren't in yet.
Orbimed Advisors LLC's record
35 other buys with 3 months of prices since 2016: on average −12.5% against the S&P 500, and 12 of 35 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Jun 9. Filed Mon, Jun 13, 5:18 PM ET, after the close. Not investment advice.